Board Committee change

Summary by AI BETAClose X

Mountview Estates PLC announced that Tracey Hartley has been appointed as the Chair of the Remuneration Committee, effective immediately, succeeding Dr. Andrew Williams who will remain on the committee. This change alters the composition of the company's board committees, with Mr. A.W. Powell now chairing the Audit and Risk Committee, Ms. Hartley chairing the Remuneration Committee, and Mr. D. M. Sinclair continuing as Chair of the Nomination Committee.

Disclaimer*

Mountview Estates PLC
26 January 2026
 

26 January 2026

MOUNTVIEW ESTATES P.L.C.

 

 

 

Mountview Estates P.L.C.

("Mountview" or "the Company")

 

Board Committee change

 

Mountview Estates P.L.C. announces that, further to its notification on 15 August 2025, Ms. Tracey Hartley has been appointed as the Chair of the Remuneration Committee, with immediate effect. Ms. Hartley succeeds Dr Andrew Williams, the Acting Chair, who will remain on the Remuneration Committee.

 

Following this change, the composition of the Company's Board Committees will be as follows:

 

 

Audit and Risk Committee

Mr A.W. Powell (Chair)

Ms T.E.B Hartley

Dr A.R. Williams

 

Remuneration Committee

Ms T.E.B. Hartley (Chair)

Dr A.R. Williams

Mr A.W. Powell

 

Nomination Committee

Mr D. M. Sinclair (Chair)

Mrs M.M. Bray

Ms T.E.B. Hartley

Mr A.W. Powell

Dr A.R Williams

 

 

~Ends~

 

 

For further information on the Company, visit: www.mountviewplc.co.uk 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings